tirzepatide elevated heart rate Tirzepatide Increased Heart Rate: Clinical Evidence and Management Should a patient with tachycardia

Liraglutide in an adolescent population with obesity: a randomized, double-blind, placebo-controlled 5-week trial to assess safety, tolerability, and pharmacokinetics of liraglutide in adolescents aged 12-17 years

are employees of WHOOP

These characteristics are amplified among those using it for diabetes management, while those using it for the purpose of weight loss specifically are younger with higher incomes

The most common first-line medical treatment is acetazolamide to reduce cerebrospinal fluid production

With regulatory decisions pending and next-generation combinations in development, the battle between Novo Nordisk and Eli Lilly for obesity market leadership is far from over